News By Country
Hong Kong SAR
University of Hong Kong
Yuen, alongside Peiris, was co-awarded the 2021 Life Science Prize for their seminal contributions to public understanding of emerging infectious diseases, including SARS in 2003 and the ongoing COVID-19 outbreak.
(Photo: University of Hong Kong)
2021 Life Science Prize Laureate
The leprosy drug clofazimine can block SARS-CoV-2 replication and even prevent the cytokine storm often seen in COVID-19 patients.
The fact that people who have recovered from COVID-19 can become reinfected suggests that immunity against SARS-CoV-2 may not be long-lasting.
Immunosuppressed mice that developed Zika had testicular inflammation that could be an important marker in humans infected with the virus.
Elderly patients could benefit from pretreatment with imiquimod before seasonal influenza vaccination.